Innovation in dementia care is revolutionizing the way we diagnose and treat older adults with neurodegenerative diseases. New tests have allowed doctors to diagnose patients with diseases like Alzheimer’s more accurately than ever before. The anti-amyloid therapies Lecanemab and Donanemab provide a real treatment for those living with Alzheimer’s. While these innovations are incredible for those experiencing dementia, they are also beginning to change our culture around dementia generally.  On this episode of the Age of Aging, Terrence Casey sits down with Dr. Jason Karlawish to talk about major steps forward in dementia care and how they’re changing the way we speak about dementia.   The topics in this conversation are pulled directly from the Dr. Karlawish’s new column, Neurotransmissions, in STAT News. Dr. Karlawish discusses the stigma-based way we talk about dementia in popular culture and the damage it does to older adults. He explains how new diagnostic tests and treatments are reshaping this culture by providing patients and caregivers with greater knowledge of their condition as well as hope for improvement. Dr. Karlawish said these changes will ultimately reduce the stigma associated with dementia and allow for further progress in the care of older adults.   Resources available on the episode webpage linked below   Read Dr. Karlawish’s column, Neurotransmissions, on STAT News    Read Illness as a Metaphor and AIDS and Its Metaphors by Susan Sontag  Learn more about LATE   Special thanks to Dr. Jason Karlawish, MD, for being a part of this episode.   The Age of Aging is a Penn Memory Center production hosted by Editorial Director Terrence Casey and Producer Jake Johnson, in partnership with the Penn FTD Center, the Penn Institute on Aging, and Penn’s Alzheimer’s Disease Research Center. Contributors include Nicolette Calcavecchia, Dalia Elsaid, Jason Karlawish, Emily Largent, and Meaghan Sharp.    The Age of Aging is made possible by generous support from the Michael Naidoff Communications Hub fund and our sponsors, the TIAA Institute and Rothkoff Law Group. The TIAA Institute is a think tank committed to building knowledge that advances lifelong financial security and well-being while considering the intersections of health and wealth. Their cutting-edge research provides actionable financial and longevity insights that help individuals and employers navigate the complex journey of aging.    Caring for an aging loved one isn’t easy — but you don’t have to do it alone. At Rothkoff Law Group, we guide families across New Jersey and Pennsylvania through every stage of your aging journey. Our team of elder care attorneys, geriatric care coordinators, and public benefits specialists advocate for your loved one’s well-being and your peace of mind. Rothkoff Law Group — your partner in advocacy and senior care planning, every step of the way...